CSSI Costas Inc.

Costas Inc. Announces Appointment of J.D. Brammer as New Chief Executive Officer and Director; Share Retirement

Costas Inc. Announces Appointment of J.D. Brammer as New Chief Executive Officer and Director; Share Retirement

NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Costas Inc. (OTC MARKETS:CSSI) Costas Inc. (CSSI or “the Company”) is proud to announce the appointment of J.D. Brammer as the new Chief Executive Officer and Director of the Company. Mr. Brammer’s appointment was made as a strategic step by the Company to pursue pending opportunities in the on-line gaming business. It will be abandoning its efforts to pursue its cryptocurrency initiatives because it has been offered a more immediately profitable venture in the online gaming market place.  As part of this change, the major stockholders have agreed to relinquish over 14,000,000 shares of their existing CSSI common stock in order to support this new initiative.

Mr. Brammer is a graduate of Stanford University and is also a former professional baseball player.  For the past fifteen years he has served as the Chief Operations Officer of Southern Amusement Company, a $50,000,000 per year revenue West Virginia Company licensed by the State of West Virginia Lottery Commission, providing gaming systems to consumers through licensed clients. Mr. Brammer is a highly respected and skilled professional manager who is broadly recognized among his peers as a “can do” “get it done” leader.  There is little doubt that Costas, under his leadership will be able to profitably and quickly launch its new initiative in the global on-line gaming market place.

J.D., brings his demonstrated talent along with years of successful, revenue producing, regulatory and business experience and unique management know-how to Costas.   “With his extensive contacts and successful management track record, we are confident that he will be able to move the Company rapidly into the on-line gaming industry”, stated Stephen Gomes, PhD, COO and Board Member of Costas. “We look forward to the opportunities that J.D. will bring to Costas and to its shareholders as he leads Costas in new profitable directions”.  The company is also pleased to announce that as part of this management change, the company is in active negotiations to merge with Southern Amusement Company.  There is no doubt that the decision to move into on-line gaming will be enhanced by the strong financial base provided by the merger with Southern Amusement Company.

Mr. Clifford Redekop has agreed to stay on as Senior Vice-President for Corporate Administration and to also remain on the board with Dr. Stephen Gomes during this period of transition.

About COSTAS (CSSI):  

COSTAS INC.  is a publicly traded company on the OTC Markets under the symbol ‘CSSI’.  Costas Inc. that is aiming to strategically partner with on-line and other gaming internationally for acquisition and strategic business.

FORWARD LOOKING STATEMENTS:

This press release and the statements of representatives of Costas, Inc. (the "Company") related thereto contain, or may contain, among other things, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are "forward-looking statements," including any other statements of non-historical information. These forward-looking statements are subject to significant known and unknown risks and uncertainties and are often identified by the use of forward-looking terminology such as "guidance," "projects," "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "ultimately" or similar expressions. All forward-looking statements involve material assumptions, risks and uncertainties, and the expectations contained in such statements may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results (including, without limitation, Costas’ ability to advance its business, generate revenue and profit and operate as a public company) could differ materially from those stated or anticipated in these forward-looking statements as a result of a variety of factors, including factors and risks discussed in the periodic reports that the Company files with OTC Markets (Pink Sheets). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. The Company undertakes no duty to update these forward-looking statements except as required by law.

For further information contact:  

  

Costas Corporate Phone Number 

702-448-2911

 

EN
29/11/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Costas Inc.

 PRESS RELEASE

Atlas Nanotech Targets the World’s Largest Consumer Health Products ...

Atlas Nanotech Targets the World’s Largest Consumer Health Products Companies to License the FirstEver Nanotechnology Vitamin A (Retinol) Based Crystalline Eye Drop GUADALAJARA, Mexico, Nov. 14, 2019 (GLOBE NEWSWIRE) -- vía OTC PR WIRE – Costas, Inc. (OTC: CSSI) DBA/Atlas Nanotech, (the “Company”) is currently in discussions to license their proprietary nanotechnology vitamin a (retinol) based crystalline eye drops known under the trade name “NANO CLEAR A”, to the leading eye drop manufactures, by licensing Nano Clear A to existing top tier eye drop manufactures it will allow the product ...

 PRESS RELEASE

Atlas Nanotech Announces the Successful Development of the First Ever ...

Atlas Nanotech Announces the Successful Development of the First Ever ‘Over The Counter’ Vitamin ‘A’ (Retinol) Eye-Drops GUADALAJARA, México, Sept. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Costas Inc. (OTC: CSSI) DBA Atlas Nanotech adds another unique nanotechnology medical product to its portfolio. Today CEO Dr. Julio Riestra announced the completion of development of the first-ever nanotechnology vitamin A (retinol) based crystalline eye drop. The product to be sold under the trade name “NANO CLEAR A” will compete with products in the treatment of dry eye disease, a $1.8-billion ...

 PRESS RELEASE

Atlas Nanotech Opens First Revenue Stream

Atlas Nanotech Opens First Revenue Stream Multipurpose contract signed with Gem Labs GUADALAJARA, Mexico, July 31, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.), DBA Atlas Nanotech, today memorialized an agreement with Laboratorios Gem S.A. de C.V. of Mexico City gemlabs.mx. The contract calls for Atlas to sell stabilized and functionalized silver nanoparticles to Gem Labs for use in the manufacture of one of Gem Labs proprietary products. This agreement represents an initial source of income for Atlas with revenue anticipated as soon as Q3 2019. The contract is unders...

 PRESS RELEASE

Atlas Nanotech of Guadalajara to begin alliance with European Nano Med...

Atlas Nanotech of Guadalajara to begin alliance with European Nano Medical S.R.O. GUADALAJARA, Mexico, June 27, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.) DBA Atlas Nanotech has entered an accord with Nano Medical S.R.O. of the Czech Republic. The first objective of the accord aims to establish distribution in new territories for both companies. A most important aspect of the accord is each company’s experience in obtaining government approval for their products in their respective territories. Atlas has successfully completed the submission of documentation and paymen...

 PRESS RELEASE

COSTAS Inc. (CSSI) Acquires Medical Nanotechnology Company, Appoints N...

COSTAS Inc. (CSSI) Acquires Medical Nanotechnology Company, Appoints New Management and Board Members LAS VEGAS, June 06, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – COSTAS,Inc.  (OTC: CSSI), announces its acquisition of Atlas Nanotech (formerly known as Nano Creaciones SAPI de CV) in an all-stock transaction that marks the Company’s entrance into the multi-billion-dollar global nanomedicine marketplace. The terms of the share exchange agreement include the appointment of new managing officers and a new board of directors, the resignation of COSTA’s current officers and board of directors ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch